Recent News

• 06.03.2026 - Magnesium Supporting Body and Mind as We Age
• 05.26.2026 - Closing the Creatine Gap: Solutions for Special Diets and Healthy, Active Aging
• 05.08.2026 - MSM for Knee Health Study: Clinical Research Supporting Knee Comfort and Quality of Life with OptiMSM®
• 05.01.2026 - Balchem Corporation Announces Global Price Increase for Animal Nutrition and Health Products
• 04.30.2026 - Balchem Reports First Quarter 2026 Financial Results
• 04.22.2026 - Balchem Releases 2025 Sustainability Report
• 04.21.2026 - How Vitamin K2 MK‑7 May Support Neuromuscular Signaling in Older Adults
• 04.16.2026 - Amino Acids: The Key to Unlocking Genetic Potential
• 04.16.2026 - Thailand FDA Approval of OptiMSM® Expands Innovation Opportunities
• 04.16.2026 - How VitaCholine® Supports Brain Health In Menopause: New Research On Working Memory And Brain Activation

Recent Filings

• 04.30.2026 - 8-K Current report
• 04.30.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 04.30.2026 - EX-99.1 EX-99.1
• 04.29.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.28.2026 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 04.27.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.27.2026 - DEF 14A Other definitive proxy statements
• 04.07.2026 - 3 Initial statement of beneficial ownership of securities